Armenian National Registry of Myocardial Infarction — ARMI  

ST Elevation Myocardial Infarction Clinical Trial

Official title: Armenian National Registry of ST-elevation Myocardial Infarction,a Multicenter Prospective Observational Study With Biocollection

Status Recruiting

Clinical Trial Summary

This is a national, multicenter prospective observational study of patients presenting to hospitals in Armenia with STEMI diagnosis. The main questions it aims to answer are: - Determine the rate of in-hospital mortality for the patients with STEMI admitted to the participating hospitals. - Compare short and long-term CV and all-cause mortality and hospitalization. - Determine how professional guidelines are followed in real-world situations.

Clinical Trial Description

Although the state program on primary percutaneous coronary intervention in ST elevated myocardial infarction, which was launched in 2015 helped to drastically decrease STEMI mortality rates, patients who had survived usually develop heart failure (HF) which leads to increased economic burden for the Armenian healthcare system. The total duration of the study will be 24 months. The target number of the inclusion is 2500 patients. The follow-up period for enrolled patients will be 12 months. ;

Related Conditions & MeSH terms

• Infarction
• Myocardial Infarction
• ST Elevation Myocardial Infarction

• NCT number: NCT06048003
• Study type: Observational [Patient Registry]
• Source: Armenian Cardiologists Association
• Contact: Hamlet G Hayrapetyan, Prof.
• Phone: +37493555050
• Email: cardioerebouni@yahoo.com
• Status: Recruiting
• Start date: December 1, 2023
• Completion date: December 30, 2025